P. Nisen

发表

p53 mutations, O6‐alkylguanine DNA alkyltransferase activity, and sensitivity to procarbazine in human brain tumors

M. Shuford, S. J. Russell, Y. Ye, 1995, Cancer.

Effects of ectopic overexpression of p21(WAF1/CIP1) on aneuploidy and the malignant phenotype of human brain tumor cells.

M. Shuford, P. Nisen, E. Rushing, 1996, Oncogene.

Data Sharing at a Crossroads.

Frank Rockhold, F. Rockhold, P. Nisen, 2016, The New England journal of medicine.

Prostate-Specific Antigen Doubling Time as a Surrogate Marker for Evaluation of Oncologic Drugs to Treat Prostate Cancer

Adam P Dicker, Anthony V D'Amico, Kathryn Z Guyton, 2004, Clinical Cancer Research.

Effects of the MYC oncogene antagonist, MAD, on proliferation, cell cycling and the malignant phenotype of human brain tumour cells

R. DePinho, N. Schreiber-Agus, P. Nisen, 1995, Nature Medicine.

Overexpression of Mad transcription factor inhibits proliferation of cultured human hepatocellular carcinoma cells along with tumor formation in immunodeficient animals

M. Ott, R. DePinho, P. Nisen, 2000, The journal of gene medicine.

Rapid Publication Tumor Suppression and Inhibition of Aneuploid Cell Accumulation in Human Brain Tumor Cells by Ectopic Overexpression of the Cyclin-dependent Kinase Inhibitor p 27 KIP 1

M. Shuford, P. Nisen, Jun Chen, 2013 .

Temperature-dependent modulation of lipopolysaccharide-induced interleukin-1 beta and tumor necrosis factor alpha expression in cultured human astroglial cells by dexamethasone and indomethacin.

J. Shay, P. Nisen, K. Olsen, 1991, The Journal of clinical investigation.

N‐myc oncogene expression and amplification in metastatic lesions of stage IV‐S neuroblastoma

P. Nisen, I. Bendit, J. Garvin, 1990, Cancer.

Effects of atrasentan on disease progression and biological markers in men with metastatic hormone-refractory prostate cancer: Phase 3 study.

F. Saad, D. Dearnaley, J. Nelson, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Enhanced expression of the N-myc gene in Wilms' tumors.

F. Alt, P. Nisen, F. Gilbert, 1986, Cancer research.

Protein synthesis-dependent induction of interleukin-1β by lipopolysaccharide is inhibited by dexamethasone via mRNA destabilization in human astroglial cells

P. Nisen, G. Mccracken, D. Kimberlin, 1995, Journal of Clinical Immunology.

Tumor suppression and inhibition of aneuploid cell accumulation in human brain tumor cells by ectopic overexpression of the cyclin-dependent kinase inhibitor p27KIP1.

M. Shuford, P. Nisen, J. Chen, 1996, The Journal of clinical investigation.

Infrequency of MDM2 gene amplification in pediatric solid tumors and lack of association with p53 mutations in adult squamous cell carcinomas.

P. Waber, P. Nisen, J. Chen, 1993, Cancer research.

The human myc gene family.

F. Alt, R. DePinho, G. Yancopoulos, 1986, Cold Spring Harbor symposia on quantitative biology.

Site-specific DNA deletions occurring adjacent to the termini of a transposable ampicillin resistance element (Tn3).

S. Cohen, P. Nisen, D. Kopecko, 1977, Journal of molecular biology.

p53, retinoblastoma, and human papillomavirus in squamous cell carcinoma and adjacent normal mucosa of the upper aerodigestive tract.

Y. Ye, P. Waber, P. Nisen, 1993, Archives of otolaryngology--head & neck surgery.

Severe chronic EBV infection associated with specific EBV immunodeficiency and an EBNA+ T-cell lymphoma containing linear, EBV DNA.

P. Nisen, V. Bonagura, B. Katz, 1990, Clinical immunology and immunopathology.

Myc family of cellular oncogenes

F. Alt, R. DePinho, G. Yancopoulos, 1987, Journal of cellular biochemistry.

N-myc Oncogene Expression in Porcine Renal Development and Oncogenesis

P. Waber, P. Nisen, B. Steinberg, 1991, Pediatric Research.

Modulation of expression of genes involved in the inflammatory response by lipopolysaccharide and temperature in cultured human astroglial cells.

P. Nisen, G. Mccracken, D. Kimberlin, 1995, Immunological investigations.

Altered fra/zs-Activational Properties of a Mutated WT1 Gene Product in a WAGR-associated Wilms' liimor1

D. Haber, P. Nisen, G. Tomlinson, 2006 .

Advances in Brief Altered fra / zs-Activational Properties of a Mutated WT 1 Gene Product in a WAGR-associated Wilms ' liimor 1

D. Haber, P. Nisen, G. Tomlinson, 2006 .

The use of early postoperative MR in detecting residual juvenile cerebellar pilocytic astrocytoma.

P. Nisen, N. Rollins, K. Shapiro, 1998, AJNR. American journal of neuroradiology.

Infrequency of p53 gene mutations in ependymomas

K. Fink, S. Schold, P. Nisen, 1996, Journal of Neuro-Oncology.

Erratum: Effects of the MYC oncogene antagonist, MAD, on proliferation, cell cycling and the malignant phenotype of human brain tumour cells (Nature Medicine (1995) 1 (638-643))

R. DePinho, Jianzhu Chen, N. Schreiber-Agus, 1995 .

Allelic loss at chromosomes 3p, 8p, 13q, and 17p associated with poor prognosis in head and neck cancer.

Y. Ye, P. Waber, P. Nisen, 1994, Journal of the National Cancer Institute.

Differential induction of the mitogen-activated protein kinase pathway by bacterial lipopolysaccharide in cultured monocytes and astrocytes.

P. Nisen, S. Willis, 1996, The Biochemical journal.

The molecular basis of severe hemophilia B in a girl.

P. Nisen, L. Waber, J. Stamberg, 1986, The New England journal of medicine.

Molecular characterization of congenital mesoblastic nephroma and its distinction from wilms Tumor

P. Nisen, S. Velasco, J. C. Argyle, 1992, Cancer.

Cytogenetics of a renal cell carcinoma in a 17-month-old child. Evidence for Xp11.2 as a recurring breakpoint.

C. Timmons, P. Nisen, G. Tomlinson, 1991, Cancer genetics and cytogenetics.

E. coli ribosomal RNA contains sequences homologous to insertion sequences IS1 and IS2

L. Shapiro, P. Nisen, 1979, Nature.

N‐myconcogene expression in histopathologically unrelated bilateral pediatric renal tumors

F. Alt, P. Nisen, M. Rich, 1988, Cancer.

Human N-myc is closely related in organization and nucleotide sequence to c-myc

F. Alt, R. DePinho, P. Nisen, 1986, Nature.

Use of CA-125 in Clinical Trial Evaluation of New Therapeutic Drugs for Ovarian Cancer

R. Bast, G. Rustin, C. Sigman, 2004, Clinical Cancer Research.

Infrequency of BRCA2 alterations in head and neck squamous cell carcinoma

A. Bowcock, P. Waber, P. Nisen, 1997, Oncogene.

N-myc oncogene RNA expression in neuroblastoma.

P. Waber, P. Nisen, M. Rich, 1988, Journal of the National Cancer Institute.

N-myc can cooperate with ras to transform normal cells in culture.

F. Alt, G. Yancopoulos, P. Nisen, 1985, Proceedings of the National Academy of Sciences of the United States of America.

Allelic loss on chromosome-13 can preceed histological-changes in head and neck-cancer.

Y. Ye, P. Nisen, N. Lee, 1994, International journal of oncology.

Frequency and Diversity of P53 Mutations in Childhood Updated Version Citing Articles E-mail Alerts Frequency and Diversity of P53 Mutations in Childhood Rhabdomyosarcoma

C. Felix, T. Mitsudomi, M. Nau, 1992 .

Nonrandom X chromosome DNA methylation patterns in hemophiliac females.

P. Waber, P. Nisen, 1989, The Journal of clinical investigation.

Infrequency of ras, p53, WT1, or RB gene alterations in Wilms tumors

P. Waber, P. Nisen, Jun Chen, 1993, Cancer.

Genetic alterations of chromosome band 9p21 – 22 in head and neck cancer are not restricted to p16INK4a

P. Waber, P. Nisen, J. Truelson, 1997, Oncogene.

Taxol, vincristine or nocodazole induces lethality in G1-checkpoint-defective human astrocytoma U373MG cells by triggering hyperploid progression.

P. Nisen, N. Schneider, J. Chen, 1999, Carcinogenesis.

Genomic imprinting and Wilms' tumor.

B. Tycko, P. Waber, P. Nisen, 1996, Medical and pediatric oncology.

Multipoint analysis of human chromosome 11p15/mouse distal chromosome 7: inclusion of H19/IGF2 in the minimal WT2 region, gene specificity of H19 silencing in Wilms' tumorigenesis and methylation hyper-dependence of H19 imprinting.

B. Tycko, C. Walsh, T. Bestor, 1999, Human molecular genetics.

Frequent allelic loss at chromosome arm 3p is distinct from genetic alterations of the Von-Hippel Lindau tumor suppressor gene in head and neck cancer.

P. Waber, P. Nisen, N. Lee, 1996, Oncogene.

Inhibition of lipopolysaccharide-induced IL-1 beta transcription by cyclic adenosine monophosphate in human astrocytic cells.

P. Nisen, S. Willis, 1995, Journal of immunology.

Downregulation of cyclin-dependent kinase 2 activity and cyclin A promoter activity in vascular smooth muscle cells by p27(KIP1), an inhibitor of neointima formation in the rat carotid artery.

P. Nisen, V. Andrés, J. Chen, 1997, The Journal of clinical investigation.

Deoxyribonucleic Acid Sequence Homologies Among Bacterial Insertion Sequence Elements and Genomes of Various Organisms

L. Shapiro, P. Nisen, M. Purucker, 1979, Journal of bacteriology.

Access to patient-level data from GlaxoSmithKline clinical trials.

Frank Rockhold, F. Rockhold, P. Nisen, 2013, The New England journal of medicine.

The endothelin axis: emerging role in cancer

J. Nelson, P. Nisen, B. Battistini, 2003, Nature Reviews Cancer.

Congenital mesoblastic nephroma with metastasis to the brain: a case report.

W. Gerald, P. Nisen, M. LaQuaglia, 1994, The American journal of pediatric hematology/oncology.

Altered trans-activational properties of a mutated WT1 gene product in a WAGR-associated Wilms' tumor.

D. Haber, P. Nisen, G. Tomlinson, 1993, Cancer research.

A glial-specific, repressible, adenovirus vector for brain tumor gene therapy.

P. Nisen, J. Chen, T. Willingham, 1998, Cancer research.

Molecular and cellular heterogeneity of wilms' tumor

C. Timmons, P. Nisen, D. D'Amico, 1993, International journal of cancer.

Molecular phenotype of a pediatric small round cell tumor

P. Waber, P. Nisen, I. Bendit, 1990, Cancer.

Access to patient-level data from GlaxoSmithKline clinical trials.

F. Rockhold, P. Nisen, 2013, The New England journal of medicine.

Myc family genes: a dispersed multi-gene family.

F. Alt, R. DePinho, G. Yancopoulos, 1986, Annals of clinical research.